This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Calidi Biotherapeutics implements 1-for-12 reverse stock split to optimize market dynamics and enhance investor appeal. Strategic move maintains shareholder value while supporting innovative cancer treatment research. #Biotech #Investment
2025-07-28T16:40:04.606Z